Related Experiment Videos
A novel but non-pathogenic mutation in exon 4 of the human amyloid precursor protein (APP) gene
G Vaula1, M Mortilla, R Tupler
1Department of Medicine and Neurology, Faculty of Medicine, University of Toronto, Ont., Canada.
Abstract:
Mutations in the beta-amyloid precursor protein (APP) gene have been associated with both familial Alzheimer disease (FAD) and with hereditary cerebral haemorrhage. The polymerase chain reaction was used to both amplify and sequence exon 4 of the APP gene from genomic DNA of subjects with FAD and normal control subjects. A novel, rare, conservative DNA sequence variant was discovered at nucleotide 459 of codon 153 (valine) in exon 4 of the APP gene in an affected member of a large FAD pedigree. Segregation studies indicate that this mutation is likely to be non-pathogenic, but must be recognized and discriminated from pathogenic mutations during sequencing studies of the APP gene in patients with FAD.
Insights
A rare variant in the beta-amyloid precursor protein (APP) gene was found in familial Alzheimer disease (FAD) patients. Segregation studies suggest this specific APP gene mutation is likely non-pathogenic.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Mutations in the beta-amyloid precursor protein (APP) gene are linked to familial Alzheimer disease (FAD) and hereditary cerebral hemorrhage.
- Genetic analysis is crucial for understanding the molecular basis of neurodegenerative disorders.
Purpose of the Study:
- To investigate the role of APP gene mutations in FAD.
- To identify and characterize novel genetic variants within the APP gene.
Main Methods:
- Polymerase chain reaction (PCR) was employed to amplify exon 4 of the APP gene.
- DNA sequencing was performed on genomic DNA from FAD subjects and healthy controls.
- Segregation analysis was conducted to assess the inheritance pattern of identified variants.
Main Results:
- A novel, rare, conservative DNA sequence variant was identified at nucleotide 459 (codon 153) in exon 4 of the APP gene.
- This variant was found in an affected member of a large FAD pedigree.
- Segregation studies indicated that this specific mutation is likely non-pathogenic.
Conclusions:
- The identified APP gene variant, while rare, does not appear to be pathogenic in the context of FAD.
- It is essential to differentiate this non-pathogenic variant from disease-causing mutations during genetic screening of FAD patients.
- Accurate genetic diagnostics are vital for understanding FAD and hereditary cerebral hemorrhage.